MA Bulletin 2020-32
Addressing COVID-19 (Coronavirus) Vaccines; Issued 12/29/2020
COMMONWEALTH OF MASSACHUSETTS
Office of Consumer Affairs and Business Regulation
DIVISION OF INSURANCE
1000 Washington Street, Suite 810 • Boston, MA 02118-6200
(617) 521-7794 • Toll-free (877) 563-4467
http://www.mass.gov/doi
CHARLES D. BAKER
GOVERNOR
KARYN E. POLITO
LIEUTENANT GOVERNOR
MIKE KENNEALY
SECRETARY OF HOUSING AND
ECONOMIC DEVELOPMENT
EDWARD A. PALLESCHI
UNDERSECRETARY OF CONSUMER AFFAIRS
AND BUSINESS REGULATION
GARY D. ANDERSON
COMMISSIONER OF INSURANCE
BULLETIN 2020-32
To:
Commercial Health Insurers, Blue Cross and Blue Shield of Massachusetts, Inc.,
and Health Maintenance Organizations
From:
Gary D. Anderson, Commissioner of Insurance
Date:
December 29, 2020
Re:
Addressing COVID-19 (Coronavirus) Vaccines
_______________________________________________________________________________
The Division of Insurance (“Division”) issues this Bulletin to provide information to Commercial
Health Insurers, Blue Cross and Blue Shield of Massachusetts, Inc., and Health Maintenance
Organizations (“Carriers”) about the Division’s expectations regarding Carriers’ appropriate
coverage of vaccines for COVID-19, a respiratory illness caused by a novel coronavirus. During
2020, the Division has issued numerous Bulletins to provide guidance to Carriers about appropriate
actions to support testing and treatment for COVID-19, including Bulletin 2020-02, which
contemplated the availablilty of vaccines for COVID-19.
Now that COVID-19 vaccines are becoming available for use, this Bulletin is intended to remind
Carriers of the need to facilitate members’ access to vaccines for COVID-19. Recognizing that
members of the public may have a number of questions and will seek a variety of methods to obtain
vaccines, the Division is indicating to all Carriers that its expectation is that members shall have
access to health insurance coverage for vaccines, and that the cost of obtaining a COVID-19 vaccine
shall not be a barrier for Massachusetts residents.
The Coronavirus Risk
The public health and societal effects resulting from the spread of COVID-19 has dramatically
impacted the Commonwealth. It is essential that government and business leaders take all
appropriate steps to safeguard the well-being of the Commonwealth’s citizens. Health insurance
coverage plays a critical role in the public’s actual and perceived access to and affordability of health
care services. The spread of COVID-19 poses unique risks to our insurance market. Therefore, the
Division is notifying Massachusetts Carriers that it expects them to take all necessary steps to enable
their covered members to obtain vaccines that will help fight the spread of this disease.
Bulletin 2020-32
December 29, 2020
Page 2 of 2
Resources Related to Vaccines
The Division expects Carriers to communicate all vaccine options to covered persons in accordance
with guidelines from the Massachusetts Department of Public Health (“DPH”), the Centers for
Disease Control and Prevention (“CDC”), and the federal Centers for Medicare and Medicaid
Services (“CMS”), such as guidelines regarding how and when to contact your local board of health
or health care provider. As this situation evolves, and informed by guidance from the DPH and
CDC, the Division may issue further Bulletins on this topic.
Specifically, the Division expects Carriers to do the following:
Develop clear and comprehensive information to be located on plan websites that will
explain how vaccines will be available, according to government guidelines, the plan’s
benefits for vaccines, and tools that will explain how to learn more about locations that will
be available to administer COVID-19 vaccines.
Maintain dedicated help lines to respond to all calls about the Coronavirus and keep covered
members aware of providers that can administer COVID-19 vaccines, members’ available
benefits, and phone numbers that members can call for additional help.
Relax prior approval requirements and procedures so that members can get timely COVID-
19 vaccines, in accordance with DPH and CDC guidelines.
Relax any and all protocols regarding prior approval or notice for obtaining vaccines from
out-of-network providers, in accordance with DPH, CDC, and CMS requirements.
Reimburse all providers, whether in-network or out-of-network, for the cost of
administering COVID-19 vaccines. Forego any cost-sharing (copayments, deductibles, or
coinsurance) for vaccinations at doctors’ offices, urgent care centers, emergency rooms,
pharmacies, or other appropriate locations in accordance with DPH and CDC requirements,
including from out-of-network providers, if vaccinations are not readily available from innetwork providers. In the event that a COVID-19 vaccine is administered in conjunction
with a full office visit not associated with COVID-19 testing, assessment or treatment,
Carriers are expected to reimburse providers for the vaccine separately if billed in that
manner, even though vaccine administration may ordinarily be bundled within
reimbursement for the full office visit.
For out-of-network providers, Carriers may limit reimbursement for the vaccine
administration to the amount set by CMS for Medicare rates of reimbursement for the same
service. For in-network providers, Carriers are expected to reimburse providers at a level
that is always higher than the MassHealth rate of reimbursement for the same service.
If you have any questions about this Bulletin, please contact Kevin Beagan, Deputy Commissioner
for the Health Care Access Bureau, at (617) 521-7323.